PL441229A1 - Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych - Google Patents

Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych

Info

Publication number
PL441229A1
PL441229A1 PL441229A PL44122922A PL441229A1 PL 441229 A1 PL441229 A1 PL 441229A1 PL 441229 A PL441229 A PL 441229A PL 44122922 A PL44122922 A PL 44122922A PL 441229 A1 PL441229 A1 PL 441229A1
Authority
PL
Poland
Prior art keywords
treatment
methods
compositions containing
synthetic peptides
malignant gliomas
Prior art date
Application number
PL441229A
Other languages
English (en)
Inventor
Katarzyna POLESZAK
Maria Pasierbińska
Aleksandra ELLERT-MIKLASZEWSKA
Paulina PILANC-KUDLEK
Paweł Wiśniewski
Bożena Kamińska-Kaczmarek
Original Assignee
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk filed Critical Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk
Priority to PL441229A priority Critical patent/PL441229A1/pl
Priority to PCT/IB2023/055089 priority patent/WO2023223241A1/en
Priority to EP23738110.8A priority patent/EP4525904A1/en
Priority to US18/858,620 priority patent/US20250282829A1/en
Publication of PL441229A1 publication Critical patent/PL441229A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem zgłoszenia są zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania do leczenia nowotworów infiltrowanych makrofagami, takich jak złośliwe glejaki.
PL441229A 2022-05-19 2022-05-19 Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych PL441229A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL441229A PL441229A1 (pl) 2022-05-19 2022-05-19 Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych
PCT/IB2023/055089 WO2023223241A1 (en) 2022-05-19 2023-05-17 Engineered synthetic peptides, compositions comprising same, and methods of use thereof for treating malignant gliomas
EP23738110.8A EP4525904A1 (en) 2022-05-19 2023-05-17 Engineered synthetic peptides, compositions comprising same, and methods of use thereof for treating malignant gliomas
US18/858,620 US20250282829A1 (en) 2022-05-19 2023-05-17 Engineered synthetic peptides, compositions comprising same, and methods of use thereof for treating malignant gliomas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL441229A PL441229A1 (pl) 2022-05-19 2022-05-19 Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych

Publications (1)

Publication Number Publication Date
PL441229A1 true PL441229A1 (pl) 2023-11-20

Family

ID=87136749

Family Applications (1)

Application Number Title Priority Date Filing Date
PL441229A PL441229A1 (pl) 2022-05-19 2022-05-19 Zaprojektowane, syntetyczne peptydy, zawierające je kompozycje i sposoby ich zastosowania w leczeniu glejaków złośliwych

Country Status (4)

Country Link
US (1) US20250282829A1 (pl)
EP (1) EP4525904A1 (pl)
PL (1) PL441229A1 (pl)
WO (1) WO2023223241A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166072A1 (en) * 2006-12-26 2011-07-07 Woei-Jer Chuang Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof
WO2013072901A2 (en) * 2011-11-17 2013-05-23 Btm Mazowsze Sp. Zo.O. Compositions and methods for treating glioma
WO2020110117A1 (en) * 2018-11-28 2020-06-04 Glia Sp. Z O.O. Compositions and methods for treating glioma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2172211T3 (pl) * 2008-10-01 2015-05-29 Immatics Biotechnologies Gmbh Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110166072A1 (en) * 2006-12-26 2011-07-07 Woei-Jer Chuang Polypeptides Selective for avB3 Integrin, Including Pegylated Polypeptides, And Pharmaceutical Uses Thereof
WO2013072901A2 (en) * 2011-11-17 2013-05-23 Btm Mazowsze Sp. Zo.O. Compositions and methods for treating glioma
WO2020110117A1 (en) * 2018-11-28 2020-06-04 Glia Sp. Z O.O. Compositions and methods for treating glioma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ATAI NA, BANSAL M, LO C, BOSMAN J, TIGCHELAAR W, BOSCH KS, JONKER A, DE WITT HAMER PC, TROOST D, MCCULLOCH CA, EVERTS V, VAN NOORD: "Immunology. 2011 Jan;132(1):39-48.", OSTEOPONTIN IS UP-REGULATED AND ASSOCIATED WITH NEUTROPHIL AND MACROPHAGE INFILTRATION IN GLIOBLASTOMA. *
PILANC-KUDLEK P, POLESZAK K, ELLERT-MIKLASZEWSKA A, ET AL.: "Journal for ImmunoTherapy of Cancer 2021;9", 615 REACTIVATING ANTITUMOR IMMUNITY IN GLIOMAS WITH OSTEOPONTIN/INTEGRIN BLOCKING PEPTIDE *

Also Published As

Publication number Publication date
EP4525904A1 (en) 2025-03-26
WO2023223241A1 (en) 2023-11-23
US20250282829A1 (en) 2025-09-11

Similar Documents

Publication Publication Date Title
BR112022019020A2 (pt) Proteínas de fusão de il12 mascaradas e métodos de uso das mesmas
MX2024014142A (es) Novedosos inhibidores de molecula peque?a de factores de transcripcion tead
EP4566621A3 (en) Dll3/cd3 binding proteins for the treatment of cancer
EA202191257A1 (ru) Противораковая терапия на основе иммуноцитов, связывающих liv1
CO2019013001A2 (es) Proteínas de anticuerpo injertadas con citocina y métodos de uso en el tratamiento del cáncer
BR112018008326A2 (pt) composições e métodos para o tratamento de câncer
EA202092590A1 (ru) Пиридазиноны в качестве ингибиторов parp7
MX2021015761A (es) Polipeptidos.
SA522432139B1 (ar) بروتينات ربط متعددة الخصوصية لمعالجة السرطان
MX383803B (es) Sintesis de n-(heteroaril)-pirrolo[3,2-d]pirimidin-2-aminas.
UA103202C2 (ru) Фармацевтическая композиция опухолеассоциированных пептидов и ее применение для лечения раковых заболеваний
BR112022008821A2 (pt) Ligantes de pseudoquinase tyk2
MX2022000310A (es) Inhibidores de proteina bcl-2.
BR112021015477A2 (pt) Anticorpos anti-cd228 e conjugados anticorpo-fármaco
MX2013008750A (es) Analogos de estilbeno y metodos para tratar cancer.
PH12021550382A1 (en) Tetrahydropyridopyrimidine derivatives as ahr modulators
EP4599893A3 (en) Cg0070 for treating bcg resistant bladder carcinoma in situ
EA201790502A1 (ru) Ингибиторы гистоновых диметилаз
BR112022000120A2 (pt) Projeto e sínteses eficientes de conjugados de lipídeo-fluoresceína para terapia de células car-t
MX2019003077A (es) Anticuerpos novedosos contra el factor xi y sus usos.
SA522431748B1 (ar) طرق لإنتاج أرجيناز 1 ناتج بمعاودة الارتباط الجيني بشري واستخداماته
MX2021011524A (es) Inhibidores de proteina arginina n-metiltransferasa 5 (prmt5) y usos de los mismos.
MX2021008834A (es) Metodos de tratamiento del cancer de mama con tucatinib.
MX2023002104A (es) Composiciones y métodos para tratar cánceres positivos para egfr.
ATE485059T1 (de) Tumortherapie mit vektoren auf sindbis virus- basis